The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation

by Luca Cozzi PhD, Tiziana Comito MD, Mauro Loi MD, Antonella Fogliata MSc, Ciro Franzese MD, Davide Franceschini MD, Elena Clerici MD, Giacomo Reggiori MSC, Stefano Tomatis MSc, Marta Scorsetti MD
Published 2020-12-01